Connect with us

Hi, what are you looking for?

Digital Health

Orygen’s Digital Mental Health Platform Comes to NSW

The MOST platform is slated to be installed in eight mental health services across the state.

Orygen’s Digital Mental Health Platform Comes to NSW

The New South Wales government has invested A$1.5 million to bring a digital mental health platform to eight of its mental health services. Its installation is targeted to be completed by 30 June next year.


The Moderated Online Social Therapy (MOST) platform provides round-the-clock integrated face-to-face and online therapy, tools and programmes for young people aged 15 to 25 with mental health issues. 

It has a network of peers and mental health clinicians supporting young patients who can also interact with other patients through the platform. MOST also gives users the ability to create their own toolkit of strategies to access before, during and after their therapy sessions.

Introduced last year in July, it is designed by Orygen, an Australian non-profit research and mental health service organisation. The digital platform can be accessed via mobile phones, tablets and desktop computers.

MOST was piloted in Victoria and was rapidly expanded there as part of the state government’s COVID-19 community support response. 


Since the pandemic, young Australians have to wait between six to eight weeks before they can secure an appointment with a psychologist at headspace, a government non-profit centre for youth mental health. Minister for Mental Health Bronnie Taylor said the installation of MOST will provide them with instant access to specialist support during this “challenging time”. It is expected that the platform will help alleviate some of the burdens faced by mental health services in the state.


The University of Sydney in July received a A$3.4 million ($2.5 million) grant from the federal government’s Clinical Trials and Cohorts Studies scheme to try out a new model of care for young people who are in the early stages of their mental health problems. The university’s Brain and Mind Centre is collaborating with Orygen, Deakin University and the University of Notre Dame for the five-year Youth Model of Care trial that will commence early next year; it will involve around 1,500 youth currently under treatment in mental health services for mood disorders.

The project will provide participating clinicians with access to a digital platform that combines measurement-based care and real-time healthcare through detailed assessment measures, longitudinal tracking and interactivity.


“MOST is changing the way we provide mental health services by connecting digital mental health technology with clinical services to address gaps in existing care models, provide on-demand support and sustain real-life recovery for young people. It is exciting that with this support of the NSW government we can now offer this world-leading digital mental health service to young people across the state,” Orygen Executive Director Patrick McGorry said.

View the original article:

Seen on Healthcare IT News: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News


PocDoc, the digital health platform and personal diagnostics provider, has launched what it says is a world-first smartphone-based test for cardiovascular disease.


Focused on connecting startups in the Medtech industry with potential investors, this can't miss event features the globe's most promising companies


The technology could greatly aid spinal surgeons in planning surgical interventions in advance.   


Emerging HealthTech company, Stasis Labs, Inc. intends to bridge the gap between clinicians and their patients with an all-in-one FDA-cleared hardware and software solution,...

You May Also Like


Today & Tomorrow: Digital Solutions in HealthTech Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare...


In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...


Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...


The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.